Sakoi M
Medical Economics Division, Health Insurance Bureau Ministry of Health and Welfare, Tokyo, Japan.
Gan To Kagaku Ryoho. 2000 Aug;27(9):1337-46.
Japan's national health expenditure has been increasing by 5% annually (approximately 1.3 trillion yen) and is expected to reach 30 trillion yen in the 1999 fiscal year. This increase is mostly due to the country's rapid aging rate. However, Japan's current slow economic growth, combined with a decrease in the average number of children per family, raises the issue of how these health-expenditure increases can be afforded as the health care system continues to provide appropriate levels of essential health care services. To understand these health-expenditure trends, one must first recognize that the Japanese health care system is characterized by the country's social health insurance system, which is based on the Social Insurance Act. It is also important to consider the impact the medical fee schedule has on clinical practices. This article reviews the situation surrounding national health-care expenditures and the related issue of social health-insurance reform. In this, several topics closely connected with cancer therapies are also examined.
日本的国民医疗支出每年以5%的速度增长(约1.3万亿日元),预计在1999财年将达到30万亿日元。这种增长主要归因于该国迅速的老龄化速度。然而,日本当前经济增长缓慢,再加上家庭平均子女数量减少,这就引发了一个问题:随着医疗保健系统继续提供适当水平的基本医疗服务,如何负担得起这些医疗支出的增加。为了理解这些医疗支出趋势,首先必须认识到日本的医疗保健系统以该国基于《社会保险法》的社会医疗保险制度为特征。考虑医疗费用表对临床实践的影响也很重要。本文回顾了国民医疗保健支出的相关情况以及社会医疗保险改革的相关问题。在此过程中,还研究了与癌症治疗密切相关的几个主题。